NYU Grossman School of Medicine is a medical school of New York University, a private research university in New York City. It was founded in 1841 and is one of two medical schools of the university, with the other being the Long Island School of Medicine.

During the past decade, New York University Langone Medical Center conducted 198 clinical trials. In the 10-year time frame, 198 clinical trials started and 133 clinical trials were completed, i.e. on average, 67.2% percent of trials that started reached the finish line to date. In the past 5 years, 66 clinical trials started and 77 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New York University Langone Medical Center" #1 sponsor was "NYU Langone Health" with 80 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 30 trials sponsored, "National Cancer Institute (NCI)" with 16 trials sponsored, "Boston Scientific Corporation" with 10 trials sponsored and "Children's Oncology Group" with 10 trials sponsored. Other sponsors include 277 different institutions and companies that sponsored additional 184 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York University Langone Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 17 trials as a collaborator, "NYU Langone Health" with 14 trials as a collaborator, "National Institute on Aging (NIA)" with 8 trials as a collaborator and "Bristol-Myers Squibb" with 6 trials as a collaborator. Other collaborators include 341 different institutions and companies that were collaborators in the rest 238 trials.

According to Clinical.Site data, the most researched conditions in "New York University Langone Medical Center" are "HIV Infections" (42 trials), "Hypertension" (12 trials), "Alzheimer Disease" (10 trials), "Alzheimer's Disease" (8 trials) and "Breast Cancer" (7 trials). Many other conditions were trialed in "New York University Langone Medical Center" in a lesser frequency.

Most popular intervention types in "New York University Langone Medical Center" are "Drug" (275 trials), "Device" (70 trials), "Other" (53 trials), "Biological" (35 trials) and "Procedure" (28 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (46 trials), "laboratory biomarker analysis" (11 trials), "Zidovudine" (10 trials), "leucovorin calcium" (10 trials) and "Carboplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "New York University Langone Medical Center" are 395 trials for "All" genders, 23 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 98 active trials in "New York University Langone Medical Center". 1 are not yet recruiting, 49 are recruiting, 42 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 264 completed trials in New York University Langone Medical Center, 1 suspended trials, and 47 terminated clinical trials to date.

Out of the total trials that were conducted in New York University Langone Medical Center, 61 "Phase 1" clinical trials were conducted, 124 "Phase 2" clinical trials and 102 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 93 trials that are defined as “Not Applicable".